Lung Nodule With High Uptake: — Cancer or Tuberculosis?

Not reliably. Both TB and lung cancer produce high FDG uptake, and the ranges overlap significantly in data from Indian centres. ASCO and NCCN guidance is consistent: a PET finding, including one with a high SUV, requires tissue confirmation before treatment. The SUV tells you the nodule is active; it cannot tell you whether it is cancer, TB, or something else. Your oncologist will use the SUV alongside many other factors, but will not treat it as a standalone diagnosis.

It helps, but not enough to replace biopsy. Irregular or spiculated margins on CT raise suspicion for malignancy; smooth, well-defined nodules are more often benign. Cavitation can appear in both TB and cancer. Your radiologist and oncologist interpret shape alongside PET findings, your history, and your risk factors. These features help estimate probability, but probability is not a diagnosis, and treatment decisions need to be based on tissue.

Watching has a real cost when cancer is a possibility: early-stage cancers respond to treatment better than advanced ones, and a nodule that has grown significantly in three months has lost ground. A repeat scan is sometimes used in specific low-risk situations to gather more information before deciding, but that is a clinical judgement your oncologist makes for your specific picture. If you are worried about the procedure, ask your chest physician to explain exactly what it involves for your nodule specifically.

It depends on where the nodule is and how accessible it is. A nodule near an airway is often sampled by bronchoscopy — a camera passed through the airway under sedation. A nodule deeper in the lung is more often reached by CT-guided needle biopsy. Some nodules require a surgical approach. Your chest physician or pulmonologist will explain which method gives the best chance of a conclusive sample from your specific nodule, and what the procedure involves step by step.

CION coordinates PET-CT through accredited partner imaging centres. The report is reviewed by your treating oncologist alongside your full clinical picture — the scan alone is never the basis for a treatment decision. If there is any question about scan quality or interpretation, your oncologist will say so and advise on next steps. Bring both the imaging disc and the written report text to every appointment; the report contains detail that the images alone do not convey.

A complete result for this situation should address both cancer and TB. Ask your oncologist whether histopathology and AFB testing were both requested when the sample was sent. A result that says 'no malignancy seen' does not mean the diagnosis is TB — both halves of the answer need to come back. If only one was tested and sample material remains, ask whether it can be used for the other. Your team should be able to tell you what is pending and when to expect it.